Key facts
- This page summarizes Charles P. Ferry's Form 4 filing for DUOS TECHNOLOGIES GROUP, INC. (DUOT).
- 4 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 30 Jan 2025, 17:26.
Charles P. Ferry - 31 Dec 2024 Form 4 Insider Report for DUOS TECHNOLOGIES GROUP, INC. (DUOT)
- Reporting relationship
- CEO, Director
- Issuer ticker
- DUOT
- Reported as of
- 31 Dec 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 30 Jan 2025, 17:26:01 UTC
- Prior SEC filing
- 08 Jul 2024
- Next SEC filing
- 10 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Charles P. Ferry
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Charles P. Ferry filed Form 4 for DUOS TECHNOLOGIES GROUP, INC. (DUOT) on 30 Jan 2025.
Change
- Previous filing in this sequence was filed on 08 Jul 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DUOT
transaction
Common Stock, $0.001 par value
Award
- Transaction value
- Shares
- +552,889
- Change %
- Price
- Shares after
- 522,889
- Date
- 01 Jan 2024
- Ownership
- Direct
- Footnotes
- F1
DUOT
holding
Common Stock, $0.001 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,374
- Date
- 31 Dec 2024
- Ownership
- Direct
DUOT
holding
Common Stock, $0.001 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 9,773
- Date
- 31 Dec 2024
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DUOT
transaction
Derivative
Options to Purchase Common Stock
Other
- Transaction value
- Shares
- +100,000
- Change %
- Price
- Shares after
- 0
- Date
- 31 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock, $0.001 par value
- Underlying amount
- 100,000
- Exercise price
- $4.20
- Footnotes
- F3, F4
DUOT
transaction
Derivative
Options to Purchase Common Stock
Other
- Transaction value
- Shares
- +100,000
- Change %
- Price
- Shares after
- 0
- Date
- 31 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock, $0.001 par value
- Underlying amount
- 100,000
- Exercise price
- $6.41
- Footnotes
- F3, F5
DUOT
transaction
Derivative
Options to Purchase Common Stock
Other
- Transaction value
- Shares
- +37,889
- Change %
- Price
- Shares after
- 0
- Date
- 31 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock, $0.001 par value
- Underlying amount
- 37,889
- Exercise price
- $4.22
- Footnotes
- F3, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The shares were granted pursuant to the Issuer's 2021 Equity Incentive Plan, as amended, and are subject to a three-year cliff vesting period. All of the shares vest on January 1, 2028.
Footnote F2
These shares owned by the reporting person are held in a joint account with the reporting person's spouse.
Footnote F3
The options were cancelled as of December 31, 2024.
Footnote F4
These options were granted pursuant to an Employment Agreement, dated September 1, 2020, between Mr. Ferry and the Issuer. The options vested in equal installments on each of September 1, 2021 and 2022.
Footnote F5
These options were granted on November 10, 2021. The options vested in three equal installments on each of November 10, 2022, 2023 and 2024.
Footnote F6
These options were granted on April 1, 2023. As of the date hereof, options to purchase 12,630 shares have vested and are exercisable. One-half of the remaining options would have vested and become exercisable on April 1, 2025 and the other half would have vested and become exercisable on April 1, 2026.